Interleukin-15 redirects the outcome of a tolerizing T-cell stimulus from apoptosis to anergy

被引:19
作者
Dooms, H
Van Belle, T
Desmedt, M
Rottiers, P
Grooten, J
机构
[1] Flanders Interuniv Inst Biotechnol, Dept Mol Biol, Mol Immunol Unit, B-9000 Ghent, Belgium
[2] Univ Ghent, B-9000 Ghent, Belgium
关键词
D O I
10.1182/blood.V96.3.1006.015k27_1006_1012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clonal deletion and anergy are 2 mechanisms used by the immune system to establish peripheral tolerance. In vitro, these mechanisms are induced in T lymphocytes by triggering the T-cell receptor (signal 1) in the absence of costimulation (signal 2). T-cell clones have been shown either to become anergic or to die in response to signal 1 alone; yet the factors that govern this choice remain unknown. This study evaluated the influence of the cytokines interleukin (IL)-2 and IL-15 on the response of the Th1 clone hemagglutinin (T-HA) to signal 1, delivered by stimulation with immobilized anti-CD3 monoclonal antibody (mAb), The response induced by immobilized anti-CDS mAb was dependent on the cytokine milieu; in the presence of IL-2, T-HA cells were subject to apoptosis, whereas in the presence of IL-15 the cells remained viable but showed proliferative unresponsiveness. After release from the anti-CDS stimulus, the IL-15-rescued T-HA cells regained responsiveness to IL-2 and IL-15 growth factor activity However, they were unable to proliferate when stimulated with their cognate antigen presented by professional antigen-presenting cells (signal 1 plus 2) and thus had acquired an anergic phenotype, These data assign a novel function to the previously reported antiapoptotic activity of IL-15, namely, the capacity to redirect the T-cell response to partial stimulation from clonal deletion to anergy, Furthermore, they emphasize that the cytokine environment can critically influence the outcome of a tolerizing stimulus. (C) 2000 by The American Society of Hematology.
引用
收藏
页码:1006 / 1012
页数:7
相关论文
共 40 条
[1]   Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-x(L)) but not pro-apoptotic (bax, bcl-x(S)) gene expression [J].
Akbar, AN ;
Borthwick, NJ ;
Wickremasinghe, RG ;
Panayiotidis, P ;
Pilling, D ;
Bofill, M ;
Krajewski, S ;
Reed, JC ;
Salmon, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (02) :294-299
[2]  
ARMITAGE RJ, 1995, J IMMUNOL, V154, P483
[3]   REVERSAL OF INVITRO T-CELL CLONAL ANERGY BY IL-2 STIMULATION [J].
BEVERLY, B ;
KANG, SM ;
LENARDO, MJ ;
SCHWARTZ, RH .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (06) :661-671
[4]   PREVENTION OF T-CELL ANERGY BY SIGNALING THROUGH THE GAMMA(C) CHAIN OF THE IL-2 RECEPTOR [J].
BOUSSIOTIS, VA ;
BARBER, DL ;
NAKARAI, T ;
FREEMAN, GJ ;
GRIBBEN, JG ;
BERNSTEIN, GM ;
DANDREA, AD ;
RITZ, J ;
NADLER, LM .
SCIENCE, 1994, 266 (5187) :1039-1042
[5]   Interleukin-15 protects from lethal apoptosis in vivo [J].
BulfonePaus, S ;
Ungureanu, D ;
Pohl, T ;
Lindner, G ;
Paus, R ;
Ruckert, R ;
Krause, H ;
Kunzendorf, U .
NATURE MEDICINE, 1997, 3 (10) :1124-1128
[6]   A LYMPHOKINE, PROVISIONALLY DESIGNATED INTERLEUKIN-T AND PRODUCED BY A HUMAN ADULT T-CELL LEUKEMIA LINE, STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
BURTON, JD ;
BAMFORD, RN ;
PETERS, C ;
GRANT, AJ ;
KURYS, G ;
GOLDMAN, CK ;
BRENNAN, J ;
ROESSLER, E ;
WALDMANN, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4935-4939
[7]   INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR [J].
CARSON, WE ;
GIRI, JG ;
LINDEMANN, MJ ;
LINETT, ML ;
AHDIEH, M ;
PAXTON, R ;
ANDERSON, D ;
EISENMANN, J ;
GRABSTEIN, K ;
CALIGIURI, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1395-1403
[8]  
CHERWINSKI HM, 1992, J IMMUNOL, V148, P2996
[9]  
DESILVA DR, 1991, J IMMUNOL, V147, P3261
[10]  
Dooms H, 1998, J IMMUNOL, V161, P2141